clinical hold

diabetes awareness
Biotech

Biomea's diabetes drug improves glucose control in ph. 2 trial

Three months after Biomea Fusion’s menin inhibitor was released from a clinical hold, the company has claimed a win in a phase 2 diabetes trial.
James Waldron Dec 17, 2024 9:50am
FDA stop sign

FDA hits pause on another of PepGen's muscular dystrophy trials

Dec 16, 2024 9:45am
FDA stop sign

FDA hits Kezar's zetomipzomib with 2nd clinical hold in 2 months

Nov 13, 2024 5:22am
FDA stop sign

Rapt's share price sinks after shelving AD drug under FDA hold

Nov 11, 2024 9:44am
FDA stop sign

FDA places Rapport's nerve damage trial on hold

Nov 7, 2024 8:50am
yellow traffic light

FDA puts partial hold on BioNTech-OncoC4 phase 3 trial

Oct 18, 2024 12:55pm